Currently, there are 164.91M common shares owned by the public and among those 124.00M shares have been available to trade.
The company’s stock has a 5-day price change of 22.98% and -4.65% over the past three months. ALAB shares are trading -33.74% year to date (YTD), with the 12-month market performance up to 25.26% higher. It has a 12-month low price of $36.22 and touched a high of $147.39 over the same period. ALAB has an average intraday trading volume of 4.32 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 30.85%, 33.93%, and 13.29% respectively.
Institutional ownership of Astera Labs Inc (NASDAQ: ALAB) shares accounts for 54.02% of the company’s 164.91M shares outstanding.
It has a market capitalization of $14.47B and a beta (3y monthly) value of 0.83. The stock’s trailing 12-month PE ratio is 374.08, while the earnings-per-share (ttm) stands at $0.23. The company has a PEG of 8.79 and a Quick Ratio of 13.26 with the debt-to-equity ratio at 0.00. Price movements for the stock have been influenced by the stock’s volatility, which stands at 7.83% over the week and 5.96% over the month.
Earnings per share for the fiscal year are expected to increase by 60.13%, and 27.53% over the next financial year.
Looking at the support for the ALAB, a number of firms have released research notes about the stock. Morgan Stanley stated their Overweight rating for the stock in a research note on May 12, 2025, with the firm’s price target at $99. Raymond James coverage for the Astera Labs Inc (ALAB) stock in a research note released on March 14, 2025 offered a Outperform rating with a price target of $82. Northland Capital was of a view on January 28, 2025 that the stock is Outperform, while Morgan Stanley gave the stock Equal-Weight rating on January 21, 2025, issuing a price target of $142. Northland Capital on their part issued Market Perform rating on January 02, 2025.
